[
    {
        "approvalNo": "国药准字S20233097",
        "name": "Herpes Zoster Vaccine, Live",
        "dosage": "injection",
        "strength": "The vial contains 0.5ml liquid by dissolution of the lyophilized vaccine with the diluent. The reconstituted vaccine contains not less than 4.3 lgPFU of live varicella-zoster virus and is used for one subjection in a single dose.",
        "marketing": "Changchun BCHT Biotechnology Co.",
        "manufacturer": "Changchun BCHT Biotechnology Co.",
        "valid": "2028-01-28",
        "approval": "2023-01-29",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20230048",
        "name": "Rabies Vaccine (Human Diploid Cell) for Human Use, Freeze-dried",
        "dosage": "Injection",
        "strength": "1.0 ml per vial after reconstitution according to the marked amount. The dose for single human use is 1.0 ml, and the titer of rabies vaccine should not be less than 2.5 IU",
        "marketing": "Beijing Minhai Biotechnology Co.,Ltd",
        "manufacturer": "Beijing Minhai Biotechnology Co.,Ltd",
        "valid": "2028-09-11",
        "approval": "2023-09-12",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20230029",
        "name": "Quadrivalent Subunit Influenza Vaccine",
        "dosage": "Injection",
        "strength": "Each pre-filled syringe is 0.5 ml. One human dose is 0.5 ml which should contain 15 µg haemagglutinin of each influenza virus strains.",
        "marketing": "Ab&B Bio-Tech CO.,LTD.JS",
        "manufacturer": "Ab&B Bio-Tech CO.,LTD.JS",
        "valid": "2028-05-11",
        "approval": "2023-05-12",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20227012",
        "name": "Influenza Vaccine (Split Virion)，Inactivated，Quadrivalent",
        "dosage": "Liquid suspension for injection",
        "strength": "0.5 mL single-dose vial / branch",
        "marketing": "JIANGSU GDK BIOLOGICAL TECHNOLOGY CO.,LTD.",
        "manufacturer": "JIANGSU GDK BIOLOGICAL TECHNOLOGY CO.,LTD.",
        "valid": "2027-08-23",
        "approval": "2022-08-24",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20217005",
        "name": "Recombinant COVID-19 Vaccine（Adenovirus Type 5 Vector）",
        "dosage": "Injection",
        "strength": "1.5ml/Vial(3 dosages),contains 1.5×10^11VP of Replication-defective Recombinant Human Type 5 Adenovirus Expressing S-protein. 0.5ml is used for single human dose,contains 5×10^10VP of Replication-defective Recombinant Human Type 5 Adenovirus Expressing S-protein.",
        "marketing": "CanSino Biologics Inc.",
        "manufacturer": "CanSino Biologics Inc.",
        "valid": "2022-02-24",
        "approval": "2021-05-26",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20210036",
        "name": "13-valent Pneumococcal Polysaccharide Conjugate Vaccine (TT/DT)",
        "dosage": "Injection",
        "strength": "0.5 ml/vial, 0.5 ml per human dose, the content of each serotype of pneumococcal polysaccharide is: 1.8 μg for serotype 1, 2.1 μg for serotype 3, 2.1 μg for serotype 4, 1.75 μg for serotype 5, 1.85 μg for serotype 6A, 4.4 μg for serotype 6B, 1.75 μg for serotype 7F, 2.3 μg for serotype 9V, 1.35 μg for serotype 14, 3.65 μg for serotype 18C, 1.6 μg for serotype 19A, 1.25 μg for serotype 19F, and 2.35 μg for serotype 23F.",
        "marketing": "Beijing Minhai Biotechnology Co.,Ltd",
        "manufacturer": "Beijing Minhai Biotechnology Co.,Ltd",
        "valid": "2026-09-06",
        "approval": "2021-09-07",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20210026",
        "name": "Rabies Vaccine（Vero Cell）for Human Use, Freeze-dried",
        "dosage": "Injection",
        "strength": "After reconstitution, the total contents is 0.5ml/vial, The individual dose is 0.5ml, and the Potency of one dose ≥2.5IU",
        "marketing": "Shandong Yidu Biotechnology Co., Ltd.",
        "manufacturer": "Shandong Yidu Biotechnology Co., Ltd.",
        "valid": "2026-07-11",
        "approval": "2021-07-12",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20210018",
        "name": "Group A and Group C Meningococcal Conjugate Vaccine（CRM197）",
        "dosage": "Injection",
        "strength": "0.5ml/vial after reconstitution according to labeled volume. 0.5ml is used for single human dose, containing 10 ug of conjugate polysaccharide A and 10ug of conjugate polysaccharide C.",
        "marketing": "CanSino Biologics Inc.",
        "manufacturer": "CanSino Biologics Inc.",
        "valid": "2026-06-21",
        "approval": "2021-06-22",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20210016",
        "name": "Haemophilus Influenzae Type b Conjugate Vaccine, Freeze-dried",
        "dosage": "Injection",
        "strength": "0.5 ml/vial after reconstitution, 0.5 ml per human dose, containing the purified Haemophilus Influenzae Type b capsular polysaccharide no less than 10 μg.",
        "marketing": "Beijing Minhai Biotechnology Co.,Ltd",
        "manufacturer": "Beijing Minhai Biotechnology Co.,Ltd",
        "valid": "2026-05-31",
        "approval": "2021-06-01",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20202001",
        "name": "Japanese Encephalitis Vaccine（Vero Cell）, Inactivated",
        "dosage": "Injection",
        "strength": "0.5mL per vial",
        "marketing": "Liaoning Cheng Da Biotechnology Co., Ltd",
        "manufacturer": "Liaoning Cheng Da Biotechnology Co., Ltd.",
        "valid": "2023-02-10",
        "approval": "2020-10-10",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20200027",
        "name": "23-valent Pneumococcal Polysaccharide Vaccine",
        "dosage": "injection",
        "strength": "0.5ml/vial (syringe), containing purified capsular polysaccharides of 23 pneumococcal types (1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, and 33F), 25 μg per type.",
        "marketing": "Sinovac Biotech Co.,Ltd.",
        "manufacturer": "Sinovac Biotech Co.,Ltd.",
        "valid": "2025-12-01",
        "approval": "2020-12-02",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20200021",
        "name": "Group A and Group C Meningococcal Conjugate Vaccine",
        "dosage": "Injection",
        "strength": "Reconstitute as the labelled volume, 0.5ml/vial, each 0.5 ml per human dose, contains 10μg of group A meningococcal polysaccharide and 10ug of group C meningococcal polysaccharide, both conjugated to tetanus toxoid, and 5.0~10.0mg of lactose.",
        "marketing": "Olymvax Biopharmaceuticals Inc.",
        "manufacturer": "Olymvax Biopharmaceuticals Inc.",
        "valid": "2025-09-29",
        "approval": "2020-09-30",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20200010",
        "name": "Influenza Vaccine (Split Virion), Inactivated, Quadrivalent",
        "dosage": "injection",
        "strength": "Each vial (syringe) contains 0.5 ml. Single dose of 0.5 ml is for adults and children aged over 3 years, containing 15 μg haemagglutinin per type of influenza virus strain.",
        "marketing": "",
        "manufacturer": "Sinovac Biotech Co.,Ltd.",
        "valid": "2025-06-16",
        "approval": "2020-06-17",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20200007",
        "name": "Influenza Vaccine（Split Virion），Inactivated，Quadrivalent",
        "dosage": "Injection",
        "strength": "0.5 ml/vial. One human dose is 0.5 ml, and it contains 15 ug hemagglutinin of each serotype of influenza virus.",
        "marketing": "",
        "manufacturer": "Wuhan Institute of Biological Products Co.,Ltd.",
        "valid": "2025-04-22",
        "approval": "2020-04-23",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20200003",
        "name": "Influenza Vaccine （Split Virion），Inactivated ，Quadrivalent",
        "dosage": "Injection",
        "strength": "0.5ml/vial (syringe),0.5ml/human dose(adults and children above 3 years old), contains 15μg hemagglutinin of each influenza virus strains",
        "marketing": "",
        "manufacturer": "Changchun Institute of Biological Products Co., Ltd.",
        "valid": "2025-03-10",
        "approval": "2020-03-11",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20200002",
        "name": "Influenza Vaccine，Live，Nasal，Freeze-dried",
        "dosage": "Nose Drops",
        "strength": "0.2ml per vial after reconstitution. Single human dose is 0.2ml, the titer of live attenuated viruses including influenza A(H1N1) and influenza A(H3N2) should be not be less than 6.9 lg EID50, and that of live attenuated viruses for influenza B should not be less than 6.4 lg EID50.",
        "marketing": "Changchun BCHT Biotechnology Co.",
        "manufacturer": "Changchun BCHT Biotechnology Co.",
        "valid": "2025-02-24",
        "approval": "2020-04-02",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20200001",
        "name": "Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine， Adsorbed",
        "dosage": "Injection",
        "strength": "0.5 ml/vial, 0.5 ml per human dose, containing at least 4.0 IU of acellular pertussis vaccine, 30 IU of diphtheria vaccine, and 40 IU of tetanus vaccine.",
        "marketing": "Beijing Minhai Biotechnology Co.,Ltd",
        "manufacturer": "Beijing Minhai Biotechnology Co.,Ltd",
        "valid": "2025-02-24",
        "approval": "2020-02-25",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20190047",
        "name": "Recombinant Human Papillomavirus Bivalent (Types 16,18) Vaccine(Escherichia coli)",
        "dosage": "injection",
        "strength": "0.5ml/vial, containing Recombinant human papillomavirus type 16 L1 protein 40μg and type 18 L1",
        "marketing": "Xiamen Innovax Biotech Co., Ltd.",
        "manufacturer": "Xiamen Innovax Biotech Co., Ltd.",
        "valid": "2024-12-29",
        "approval": "2019-12-30",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20190046",
        "name": "13-Valent Pneumococcal Polysaccharide Conjugate Vaccine",
        "dosage": "Injection",
        "strength": "0.5ml/vial, each single human dose is 0.5ml containing pneumococcal polysaccharide for serotype 1 2.6μg, serotype 3 2.5μg, serotype 4 3.0μg, serotype 5 2.5μg, serotype 6A 2.5μg, serotype 7F 2.85μg, serotype 9V 2.5μg, serotype 14 2.75μg, serotype 18C 3.25μg, serotype 19A 2.6μg, serotype 19F 2.75μg, serotype 23F 3.0μg and serotype 6B 6.0μg",
        "marketing": "",
        "manufacturer": "Yuxi Walvax Biotechnology Co.,Ltd",
        "valid": "2024-12-29",
        "approval": "2019-12-30",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20190044",
        "name": "Varicella Vaccine,Live",
        "dosage": "Injection",
        "strength": "0.5mL/vial after reconstitution, 0.5mL per single human dose shall contain not less than 3.3 lg of PFU of live varicella-herpes zoster virus.",
        "marketing": "",
        "manufacturer": "Sinovac (Dalian) Vaccine Technology Co., Ltd.",
        "valid": "2024-12-17",
        "approval": "2019-12-18",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20190026",
        "name": "Influenza Vaccine (Split Virion)，Inactivated，Quadrivalent",
        "dosage": "Liquid suspension for injection",
        "strength": "0.5 mL single-dose vial / box",
        "marketing": "",
        "manufacturer": "JIANGSU GDK BIOLOGICAL TECHNOLOGY CO.,LTD.",
        "valid": "2024-05-20",
        "approval": "2019-05-21",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20184001",
        "name": "Haemophilus Influenzae Type b Conjugate Vaccine",
        "dosage": "Injection",
        "strength": "Each 0.5ml (pre-filled syringe), 0.5ml per time inoculation for person use containing not less than 10μg of purified Haemophilus influenzae type b polysaccharide",
        "marketing": "",
        "manufacturer": "Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd.",
        "valid": "2021-09-18",
        "approval": "2018-01-08",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20181000",
        "name": "Group A and C Meningococcal Polysaccharde Vaccine",
        "dosage": "Injection",
        "strength": "Each 0.5ml (pre-filled syringe), 0.5ml per time inoculation for person use containing 10μg of each of the meningococcal polysaccharide group A and C combined with tetanus toxoid",
        "marketing": "",
        "manufacturer": "Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd.",
        "valid": "2022-06-25",
        "approval": "2018-01-03",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20180014",
        "name": "Poliomyelitis Vaccine Type I Type III in Dragee Candy (Human Diploid Cell), Live",
        "dosage": "Dragee Candy",
        "strength": "1g/piece",
        "marketing": "",
        "manufacturer": "Institute of Medical Biology Chinese Academy of Medical Sciences",
        "valid": "2023-10-14",
        "approval": "2018-10-15",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20180013",
        "name": "Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral",
        "dosage": "Liquid (Oral)",
        "strength": "1.0ml/ dropper, 10 doses per dropper",
        "marketing": "",
        "manufacturer": "Institute of Medical Biology Chinese Academy of Medical Sciences",
        "valid": "2023-10-14",
        "approval": "2018-10-15",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20180012",
        "name": "Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral",
        "dosage": "Liquid (Oral)",
        "strength": "0.5ml/ dropper, 5 doses per dropper",
        "marketing": "",
        "manufacturer": "Institute of Medical Biology Chinese Academy of Medical Sciences",
        "valid": "2023-10-14",
        "approval": "2018-10-15",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20180011",
        "name": "Group ACYW135 Meningococcal Polysaccharide Vaccine",
        "dosage": "Injection",
        "strength": "Each single human dose of the product contains 1 vial of vaccine and 1 vial of diluent. 0.5ml of the vaccine per vial after reconstitution. 0.5ml per single human dose, containing group A,C,Y, W135 capsular polysaccharide respectively 50 μg.",
        "marketing": "",
        "manufacturer": "Aimei Vacin BioPharm (Zhejiang) Co., Ltd.",
        "valid": "2023-10-14",
        "approval": "2018-10-15",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20180009",
        "name": "23-Valent Pneumococcal Polysaccharide Vaccine",
        "dosage": "Injection",
        "strength": "0.5 mL/vial, 0.5 ml per human dose, containing purified pneumococcal capsular polysaccharide of 23 serotypes (25 μg each).",
        "marketing": "",
        "manufacturer": "Beijing Minhai Biotechnology Co.,Ltd",
        "valid": "2023-08-11",
        "approval": "2018-08-12",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20180006",
        "name": "Influenza Vaccine(Split Virion)， Inactivated，Quadrivalent",
        "dosage": "Injection",
        "strength": "0.5 ml per vial (syringe). 0.5ml human dose for each use, contains 15μg HA of each type of influenza strains.",
        "marketing": "",
        "manufacturer": "Hualan Biological Bacterin Inc.",
        "valid": "2023-06-07",
        "approval": "2018-06-08",
        "licenser": "China"
    },
    {
        "approvalNo": "国药准字S20180001",
        "name": "Group A and C Meningococcal Polysaccharide Vaccine",
        "dosage": "Injection",
        "strength": "0.5ml per vial and 0.5ml per person dose after re-dissolution, containing 50μg of Group A and Group C polysaccharides respectively.",
        "marketing": "",
        "manufacturer": "Hualan Biological Bacterin Inc.",
        "valid": "2023-03-11",
        "approval": "2018-03-12",
        "licenser": "China"
    },
    {
        "approvalNo": "#",
        "name": "ChAdOx1 nCoV-19 Corona Virus vaccine (Recombinant) (COVISHIELD)",
        "dosage": "Injection",
        "strength": "Intramuscular, 2-8°C storage, 2 doses, 4 to 6 weeks apart (or 12 weeks as per overseas data)",
        "marketer": "Serum Institute of India Pvt. Ltd.",
        "manufacturer": "Serum Institute of India Pvt. Ltd.",
        "valid": "9 months from approval date",
        "approval": "2022-01-27",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "Whole-Virion Inactivated SARS-CoV-2 Vaccine (COVAXIN)",
        "dosage": "Injection",
        "strength": "Intramuscular, 2-8°C storage, 2 doses on Day 0 and 28",
        "marketer": "Bharat Biotech",
        "manufacturer": "Bharat Biotech",
        "valid": "12 months from approval date",
        "approval": "2022-01-27",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "Gam COVID Vac (component I & II) (SPUTNIK-V)",
        "dosage": "Injection",
        "strength": "Intramuscular, -18°C storage, 2 doses: Day 0 (component I) and Day 21 (component II)",
        "marketer": "Dr. Reddy’s Lab. Ltd. (Importer)",
        "manufacturer": "Dr. Reddy’s Lab. Ltd. (Importer)",
        "valid": "12 months from approval date",
        "approval": "2021-04-12",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "mRNA-1273 COVID-19 vaccine (Moderna vaccine)",
        "dosage": "Injection",
        "strength": "Intramuscular, -25ºC to -15ºC storage, 2 doses: Day 0 and 28",
        "marketer": "Cipla Ltd. (Importer)",
        "manufacturer": "Cipla Ltd. (Importer)",
        "valid": "7 months from approval date",
        "approval": "2021-06-29",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "Gam COVID Vac (component I & II) (SPUTNIK-V)",
        "dosage": "Injection",
        "strength": "Intramuscular, -18°C storage, 2 doses: Day 0 (component I) and Day 21 (component II)",
        "marketer": "Panacea Biotec Ltd",
        "manufacturer": "Panacea Biotec Ltd",
        "valid": "12 months from approval date",
        "approval": "2021-07-02",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "COVID-19 vaccine (Ad26.COV2-S) [recombinant] (Janssen Vaccine)",
        "dosage": "Injection",
        "strength": "Intramuscular, -25ºC to -15ºC & 2-8°C storage, single dose",
        "marketer": "Johnson & Johnson Pvt. Ltd. (Importer)",
        "manufacturer": "Johnson & Johnson Pvt. Ltd. (Importer)",
        "valid": "6 months from approval date",
        "approval": "2021-08-07",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "COVID-19 vaccine (Ad26.COV2-S) [recombinant] (Janssen Vaccine)",
        "dosage": "Injection",
        "strength": "Intramuscular, -25ºC to -15ºC & 2-8°C storage, single dose",
        "marketer": "Biological E Limited",
        "manufacturer": "Biological E Limited",
        "valid": "6 months from approval date",
        "approval": "2021-08-18",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "Novel Corona Virus-2019-nCov vaccine (rDNA) (ZyCoV-D)",
        "dosage": "Intradermal Injection",
        "strength": "2-8°C storage, three doses on Day 0, 28 & 56",
        "marketer": "Cadila Healthcare Limited",
        "manufacturer": "Cadila Healthcare Limited",
        "valid": "12 months from approval date",
        "approval": "2021-08-20",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "Gam COVID Vac (component I & II) (SPUTNIK-V)",
        "dosage": "Injection",
        "strength": "Intramuscular, -18°C storage, 2 doses: Day 0 (component I) and Day 21 (component II)",
        "marketer": "Hetero Biopharma Ltd",
        "manufacturer": "Hetero Biopharma Ltd",
        "valid": "6 months from approval date",
        "approval": "2021-10-07",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "Whole-Virion Inactivated SARS-CoV-2 Vaccine (COVAXIN)",
        "dosage": "Injection",
        "strength": "Intramuscular, 2-8°C storage, 2 doses on Day 0 and 28",
        "marketer": "Bharat Biotech",
        "manufacturer": "Bharat Biotech",
        "valid": "12 months from approval date",
        "approval": "2021-12-24",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "SARS-CoV-2 vaccine containing Receptor Binding Domain (RBD) of SARS-CoV-2 gene (CORBEVAX)",
        "dosage": "Injection",
        "strength": "Intramuscular, 2-8°C storage, 2 doses on Day 0 and 28",
        "marketer": "Biological E Limited",
        "manufacturer": "Biological E Limited",
        "valid": "18 months from approval date",
        "approval": "2021-12-28",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine [COVOVAX]",
        "dosage": "Injection",
        "strength": "Intramuscular, 2-8°C storage, 2 doses on Day 0 and 21",
        "marketer": "Serum Institute of India Pvt. Ltd.",
        "manufacturer": "Serum Institute of India Pvt. Ltd.",
        "valid": "9 months from approval date",
        "approval": "2021-12-28",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "Recombinant adenoviral vector vaccine containing particles of serotype 26 containing the protein S gene of the SARS-CoV-2 virus (SPUTNIK Light)",
        "dosage": "Injection",
        "strength": "Intramuscular, -18°C storage, single dose",
        "marketer": "Dr. Reddy’s Lab. Ltd. (Importer)",
        "manufacturer": "Dr. Reddy’s Lab. Ltd. (Importer)",
        "valid": "6 months from approval date",
        "approval": "2022-02-05",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "Recombinant adenoviral vector vaccine containing particles of serotype 26 containing the protein S gene of the SARS-CoV-2 virus (SPUTNIK Light)",
        "dosage": "Injection",
        "strength": "Intramuscular, -18°C storage, single dose",
        "marketer": "Hetero Biopharma Ltd",
        "manufacturer": "Hetero Biopharma Ltd",
        "valid": "6 months from approval date",
        "approval": "2022-03-16",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "Novel Corona Virus-2019-nCov vaccine (rDNA) (ZyCoV-D)",
        "dosage": "Intradermal Injection",
        "strength": "Intramuscular, 2-8°C storage, two doses on Day 0 and 28",
        "marketer": "Cadila Healthcare Limited",
        "manufacturer": "Cadila Healthcare Limited",
        "valid": "9 months from approval date",
        "approval": "2022-04-26",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "Lyophilized mRNA Vaccine for Injection (COVID-19) [HGCO-19]",
        "dosage": "Injection",
        "strength": "Intramuscular, 2-8°C storage, two doses on Day 0 and 28",
        "marketer": "Gennova Biopharmaceuticals Limited",
        "manufacturer": "Gennova Biopharmaceuticals Limited",
        "valid": "6 months from approval date",
        "approval": "2022-06-28",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant COVID-19 Vaccine [iNCOVACC]",
        "dosage": "Intranasal",
        "strength": "2 doses on Day 0 and 28, 2-8°C storage",
        "marketer": "Bharat Biotech",
        "manufacturer": "Bharat Biotech",
        "valid": "6 months from approval date",
        "approval": "2022-09-06",
        "licenser": "India"
    },
    {
        "approvalNo": "#",
        "name": "SARS-CoV-2 vaccine containing Receptor Binding Domain (RBD) of SARS-CoV-2 gene (CORBEVAX) Booster dose",
        "dosage": "Injection",
        "strength": "Single dose booster administered 6 months after primary vaccination with COVAXIN & COVISHIELD, 2-8°C storage",
        "marketer": "Biological E Limited",
        "manufacturer": "Biological E Limited",
        "valid": "",
        "approval": "2022-06-03",
        "licenser": "India"
    }
]